Portrait photo of iRhythm's next CCO Chad Patterson
iRhythm’s next CCO Chad Patterson [Image from Patterson’s LinkedIn page]

iRhythm Technologies (Nasdaq:IRTC) announced today that it appointed Chad Patterson as its next chief commercial officer.

Patterson will join the wearable electrocardiogram monitors developer’s executive leadership team and, as CCO, he will oversee the company’s commercial strategy, operations and execution.

He most recently served as chief marketing officer at Dexcom. He will make the move from the continuous glucose monitor developer to iRhythm just as president and CEO Quentin Blackford did in September of 2021.

“As iRhythm expands within its core U.S. markets, into additional international geographies, and into adjacent markets, we are excited to welcome Chad to our executive team,” Blackford said in a news release. “Chad joins us at the perfect time to leverage his experience in driving significant growth in global markets as we look to execute against our renewed corporate strategy. With his track record of execution and wealth of experience, his data-driven approach to sales and marketing strategies and operations will allow us to continue to evolve as a market leader in the space.”

Patterson will join the company following the resignation of Dave Vort, whose resignation will be made effective on July 25, 2022. Vort will continue to serve as a strategic advisor through March 31, 2023.

“We are grateful to Dave for his many contributions over the past eight and a half years, leading iRhythm from its early commercial days through periods of transformational growth,” Blackford said. “Dave was instrumental in building our world-class commercial organization and has played a key role in our ongoing success. We thank Dave for all that he has done for iRhythm and look forward to his continued contributions as a strategic advisor.”

While announcing the CCO transition, iRhythm also announced that it expects its upcoming quarterly earnings for the three months ended June 30 to be slightly ahead of expectations, with the company maintaining its projection of revenues between $410 million and $420 million for the full year.

“While preliminary, we are pleased with our second quarter volumes that demonstrated steady growth in our core U.S. market at rates slightly ahead of expectations as well as another quarter of record registrations,” Blackford said. We look forward to providing additional information during our second quarter 2022 earnings release in August.”